Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-11-30

Clinical Trial Update: Glucose-dependent Asprosin Dynamics

View source ↗

Summary

A Heidelberg University-sponsored clinical trial investigating glucose-dependent asprosin dynamics in diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Heidelberg University | Conditions: Diabetes Mellitus | Status: COMPLETED